Showing results (581-590 of 664) with videos related to

Sort By:
Pageof 67
Breast Cancer Research and Treatment|January 11, 2016
A phase II trial of trabectedin in triple-negative and HER2-overexpressing metastatic breast cancerJoanne L Blum, Anthony Gonçalves, Noa Efrat, et al.
Stem Cells (Dayton, Ohio)|January 24, 2012
Induction of osteogenesis in mesenchymal stem cells by activated monocytes/macrophages depends on oncostatin M signalingPierre Guihard, Yannic Danger, Bénédicte Brounais, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1983
High-dose cyclophosphamide with autologous marrow transplantation for small cell carcinoma of the bronchusR L Souhami, P G Harper, D Linch, et al.
Clinical and Experimental Immunology|May 3, 2000
Intra-articular IL-10 gene transfer regulates the expression of collagen-induced arthritis (CIA) in the knee and ipsilateral pawE Lubberts, L A Joosten, L Van Den Bersselaar, et al.
British Journal of Haematology|June 1, 1992
Mini-BEAM followed by BEAM and ABMT for very poor risk Hodgkin's diseaseR Chopra, D C Linch, A K McMillan, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|May 25, 2019
Adjuvant Chemotherapy for Breast Cancer in Older Women: An Analysis of Retrospective English Cancer Registration DataS E Ward, G R Holmes, A Ring, et al.
Scientific Reports|April 26, 2018
Assessing the Nature of the Distribution of Localised States in Bulk GaAsBiTom Wilson, Nicholas P Hylton, Yukihiro Harada, et al.
Frontiers in Microbiology|July 23, 2016
Dephosphorylation of the Core Septin, AspB, in a Protein Phosphatase 2A-Dependent Manner Impacts Its Localization and Function in the Fungal Pathogen Aspergillus fumigatusJosé M Vargas-Muñiz, Hilary Renshaw, Amber D Richards, et al.
Nature Communications|August 7, 2021
Valence band engineering of GaAsBi for low noise avalanche photodiodesYuchen Liu, Xin Yi, Nicholas J Bailey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 1999
Phase I evaluation of ISIS 3521, an antisense oligodeoxynucleotide to protein kinase C-alpha, in patients with advanced cancerJ Nemunaitis, J T Holmlund, M Kraynak, et al.
Pageof 67